New incident report
Incident Report Number: 2022-0588
Registrant Reference Number: 2971626
Registrant Name (Full Legal Name no abbreviations): Bayer CropScience Inc.
Address: 160 Quarry Park Boulevard SE Suite 130
City: CALGARY
Prov / State: AB
Country: Canada
Postal Code: T2C 3G3
Human
Country: CANADA
Prov / State: ALBERTA
PMRA Registration No. 33248 PMRA Submission No. EPA Registration No.
Product Name: Infinity FX
PMRA Registration No. 29070 PMRA Submission No. EPA Registration No.
Product Name: VARRO HERBICIDE
No
Unknown
Unknown
Data Subject
Sex: Male
Age: >19 <=64 yrs / >19 <=64 ans
System
<=30 min / <=30 min
Unknown
No
Non-occupational
What was the activity? Please refer to field 13 on Subform II or field 17 of subform III for a detailed description regarding the activity
Pesticide Spill
Poisoning from ingestion of the pesticide
Unknown
Skin
Eye
Oral
<=15 min / <=15 min
<=30 min / <=30 min
6/3/2021 Caller was just about to apply the products in his yard, when a line on the sprayer ruptured 20 minutes ago. The products were mixed and diluted already in the spray tank. Caller was sprayed all over his body and some got into his mouth. The product got on his glasses and some contacted his eyes, but it wasn't a direct hit. He rinsed everywhere with a garden hose for 2 to 3 minutes, then took off his clothes and showered for 10 minutes. Initially his eyes were a little red, but they aren't red now. He had the taste of chemicals in his mouth. He doesn't believe he swallowed anything as he started spitting right away. He rinsed his mouth out with water and several times with mouth wash. He doesn't have the taste in his mouth at this time.
Minor
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.